Johnson & Johnson(JNJ) - Stock detail

Johnson & Johnson

US
JNJ
Johnson & Johnson(Listing date: 09/25/1944)

Johnson & Johnson was incorporated in New Jersey in 1887. Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacturing and sale of various products in the healthcare field. Johnson & Johnson is a holding company, with its operating companies located in nearly all countries around the world. The company's primary focus is on products related to human health and well-being. The company is divided into two business segments: Innovative Medicine and MedTech.

AI Technical AnalystHold
Rating5/10
Generated at:2026-03-04 16:37:05
Analysis based on data from 2025-12-05 to 2026-03-04, covering 90 calendar days and 60 trading days, using technical indicators and historical price patterns from US stock market data
Insight

Johnson & Johnson exhibits a technically sound bullish structure but shows signs of near-term consolidation with momentum indicators suggesting limited upside without significant catalysts.

Resistance
251.71
Support
199.91
Support and resistance are estimated from the latest 60 sessions.
Strategy
  • Short-term:Hold position with caution, monitor for consolidation around $243-249 range, consider partial profits near $248-250 resistance if reached
  • Mid-term:Maintain moderate position size with stop-loss at $235.00, expect 30-45 day holding period based on historical patterns
  • Long-term:Monitor for breakout above $249 resistance for continued bullish momentum, maintain defensive positioning appropriate for healthcare sector characteristics

Moving averages

MA 5
246.50
MA 20
243.28
MA 60
222.95
Price
245.30
AI Analysis
  • Clear bullish moving average configuration with hierarchical alignment: MA_5 ($246.50) > MA_10 ($245.92) > MA_20 ($243.28) > MA_60 ($222.95)
  • Multi-tiered bullish structure indicates strong underlying trend strength
  • Current price of $245.30 trades above all key moving averages
  • Significant gap between MA_20 ($243.28) and MA_60 ($222.95) highlights momentum of recent advance

Volume

Volume
5.45M
20D Avg
9.07M
Institution
-
Participation
-
AI Analysis
  • Trading volume shows typical patterns for Johnson & Johnson
  • Recent volume of 5.45 million shares represents average participation relative to 60-day range
  • Volume spikes accompanied key breakout moves, such as January 13-16 period
  • Volumes exceeding 10 million shares confirmed institutional participation in the advance

MACD

MACD
5.83
Signal
6.66
Hist
-0.83
Trend
-
AI Analysis
  • MACD indicator presents mixed signal with MACD at 5.8258, MACD Signal at 6.6594, and MACD Histogram at -0.8336
  • Negative histogram indicates potential near-term momentum deceleration
  • Overall positive MACD reading suggests stock may be entering consolidation phase within broader uptrend

Bollinger bands

Upper
250.94
Middle
243.28
Lower
235.63
Width
6.29%
AI Analysis
  • Trading within Bollinger Bands with current price ($245.30) positioned between middle band ($243.28) and upper band ($250.94)
  • Band width of approximately $15.31 indicates moderate volatility
  • Price position relative to bands suggests JNJ is in normal trading range without extreme overbought or oversold conditions

RSI

RSI(14)
63.78
RSI(6)
51.15
Overbought
70+
Oversold
30-
AI Analysis
  • RSI reading of 63.78 indicates JNJ is in bullish territory but approaching overbought threshold (typically 70)
  • RSI_6 at 51.15 shows neutral short-term momentum
  • Combination suggests stock has room for further advancement but may face near-term resistance as momentum indicators moderate

KDJ

K
60.86
D
70.01
J
42.58
Trend
-
AI Analysis
  • KDJ readings show mixed signals: K: 60.86, D: 70.01, J: 42.58
  • D value above 70 suggests potential overbought conditions
  • J value at 42.58 indicates room for upward movement
  • Divergence suggests near-term consolidation potential

Chip distribution

How chip distribution helps you?
Chip distribution summary
  • Most holders are near breakeven with 68.93% profitable positions and potential resistance around $248-249 level where significant profit-taking may occur.
  • 68.93% of positions are profitable at current prices
  • Average cost basis of $243.72, very close to current price
  • 90% of chips concentrated between $214.68-$248.81 (7.36% concentration)
  • 70% of chips concentrated between $227.75-$246.63 (3.98% concentration)
  • Most holders are near breakeven or slightly profitable
  • Creates potential resistance around $248-249 level where significant profit-taking may occur
  • Relatively tight concentration ranges indicate consensus among market participants about fair value
No chart data

Data is estimated based on turnover rate, high, low, open, and close prices. Profit ratios may vary significantly across different brokerage tools.